©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 26, 2024; 12(27): 6007-6010
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6007
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6007
Trends in upper gastrointestinal bleeding management
Yasir M Khayyat, Department of Medicine, Faculty of Medicine, Umm AL-Qura University, Makkah 8156-24381, Saudi Arabia
Author contributions: Khayyat YM contributed to conceptualization, drafting, and revision of the editorial manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Corresponding author: Yasir M Khayyat, FACG, FACP, FRCP (C), Professor, Department of Medicine, Faculty of Medicine, Umm AL-Qura University, AlAwali District, Makkah 8156-24381, Saudi Arabia. ymkhayyat@uqu.edu.sa
Received: March 6, 2024
Revised: June 15, 2024
Accepted: June 26, 2024
Published online: September 26, 2024
Processing time: 146 Days and 9.7 Hours
Revised: June 15, 2024
Accepted: June 26, 2024
Published online: September 26, 2024
Processing time: 146 Days and 9.7 Hours
Core Tip
Core Tip: Non-variceal upper gastrointestinal bleeding (NVUGIB) is a medical emergency that requires assessment of patient factors, hemodynamic parameters, and laboratory work to determine the patient’s prognosis and treatment. Patients with low-risk NVUGIB are typically discharged quickly, while patients with high-risk NVUGIB may require administration of volume replacement, blood transfusion, and high-dose intravenous proton pump inhibitors. These high-risk patients also require urgent upper endoscopy. Evaluation of the need for anticoagulant and analgesics after discharge is also needed.